Product Wiki · Recalls · Health Canada — Drugs and Health Products

APO-AMITRIPTYLINE 10mg — recall 72672

Health Canada — Drugs and Health Products · Canada · 2023-02-07 · Type I

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Drugs and Health Products
Recall identifier
72672
Date of alert
2023-02-07
Country / jurisdiction
Canada
Risk level
Type I
Risk type
recall
Product category
Drugs
Product type
Drugs and health products
Reported risk: Contamination - Product safety
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/apo-amitriptyline-10mg-ndma-im

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.